Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease

  title={Oropharyngeal Dysphagia in Infants and Children with Infantile Pompe Disease},
  author={Harrison N. Jones and Carolyn W. Muller and Min Lin and Suhrad G. Banugaria and Laura Case and Jennifer S. Li and Gwendolyn O’Grady and James H. Heller and Priya Kishnani},
Pompe disease is a rare genetic progressive neuromuscular disorder. The most severe form, infantile Pompe disease, has historically resulted in early mortality, most commonly due to cardiorespiratory failure. Treatment with enzyme replacement therapy (ERT) using alglucosidase alfa (Myozyme®) has extended the lifespan of individuals with this disease. With the introduction of ERT and the resultant improved survival, dysphagia is being encountered clinically with increasing regularity though… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 22 extracted citations

Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society • 2017
View 1 Excerpt

Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques • 2016
View 1 Excerpt

Longitudinal polysomnographic findings in infantile Pompe disease.

American journal of medical genetics. Part A • 2015
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 27 references

Motor assessment of the developing infant

MC Piper, J. Darrah
View 12 Excerpts
Highly Influenced

Language and speech function in children with infantile Pompe disease

CS Muller, HN Jones, +3 authors PS. Kishnani
J Pediatr Neurol • 2009
View 3 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…